Abstract: In an example, a computing device is described. The computing device comprises a communication interface and a processor. The processor is to determine whether a signature, produced by a signer, is derived from a free state under a stateful signature scheme. The free state is a state that has not been used as an input to generate a signing key. The signature is encrypted by the signer. The processor is further to, in response to determining that the signature is derived from a free state, decrypt the encrypted signature. The processor is further to transmit the decrypted signature to a recipient via the communication interface.

Abstract: Examples relate to verifying network elements. In one example, a computing device may: receive, from a client device, a request for attestation of a back-end network, the request including back-end configuration requirements; obtain, from a network controller that controls the back-end network, a controller configuration that specifies each network element included in the back-end network; provide each network element included in the back-end network with a request for attestation of a network element configuration of the network element; receive, from each network element, response data that specifies the network element configuration of the network element; verify that the response data received from each network element meets the back-end configuration requirements included in the request for attestation of the back-end network; and provide the client device with data verifying that the back-end network meets the back-end configuration requirements.

Abstract: Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions. Also provided herein are compositions useful in the production of glycopyrronium tosylate. Additionally provided herein are glycopyrronium tosylate compositions. Glycopyrronium tosylate is useful for the treatment of, among other conditions, hyperhidrosis.

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Abstract: Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals. Disclosed here are processes for making salts of glycopyrronium, also processes for making compositions comprising salts of glycopyrronium, and methods of treating hyperhidrosis with salts of glycopyrronium as well as with compositions comprising salts of glycopyrronium such as, but not limited to, topical compositions. Disclosed herein are methods of treating hyperhidrosis including administering salts of glycopyrronium to subjects in need thereof.

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Abstract: Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals. Disclosed here are processes for making salts of glycopyrronium, also processes for making compositions comprising salts of glycopyrronium, and methods of treating hyperhidrosis with salts of glycopyrronium as well as with compositions comprising salts of glycopyrronium such as, but not limited to, topical compositions. Disclosed herein are methods of treating hyperhidrosis including administering salts of glycopyrronium to subjects in need thereof.

Abstract: Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals. Disclosed here are processes for making salts of glycopyrronium, also processes for making compositions comprising salts of glycopyrronium, and methods of treating hyperhidrosis with salts of glycopyrronium as well as with compositions comprising salts of glycopyrronium such as, but not limited to, topical compositions. Disclosed herein are methods of treating hyperhidrosis including administering salts of glycopyrronium to subjects in need thereof.

Abstract: Examples relate to Input/Output (I/O) data encryption and decryption. In an example, an encryption/decryption engine on an Integrated Circuit (IC) of a computing device obtains at least one plaintext data. Some examples determine, by the encryption/decryption engine, whether the at least one plaintext data is to be sent to a memory in the computing device or to an I/O device. Some examples apply, when the at least one plaintext data is to be sent to the I/O device and by the encryption/decryption engine, an encryption primitive of a block cipher encryption algorithm to the at least one plaintext data to create output encrypted data, wherein an initialization vector that comprises a random number is applied to the encryption primitive.

Abstract: Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions. Also provided herein are compositions useful in the production of glycopyrronium tosylate. Additionally provided herein are glycopyrronium tosylate compositions. Glycopyrronium tosylate is useful for the treatment of, among other conditions, hyperhidrosis.

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Abstract: Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Abstract: Example implementations relate to non-volatile storage of management data. In example implementations, a system is disclosed, the system including a plurality of computing devices, a management device, and a non-volatile memory including a plurality of management spaces corresponding to the plurality of computing devices. In example implementations, at least one of the plurality of management spaces is to be accessible by the management device and by the corresponding computing device, be inaccessible by computing devices other than the corresponding computing device, and store management data associated with the corresponding computing device.

Abstract: A computing device having instructions that when executed by a processor may: receive, from a verifier, a request for attestation of a current network configuration of the computing device; identify network configuration rules, each network configuration rule specifying an action to be taken by the computing device in response to receiving a particular type of network traffic; generate, for each network configuration rule, a rule abstraction that represents the network configuration rule; provide data representing each rule abstraction to a trusted component; receive, from the trusted component, response data comprising i) data representing each rule abstraction, and ii) a digital signature; and provide the response data to the verifier as attestation proof of the current network configuration of the computing device.

Abstract: Provided herein are methods for the production of glycopyrronium tosylate and glycopyrronium tosylate compositions. Also provided herein are compositions useful in the production of glycopyrronium tosylate. Additionally provided herein are glycopyrronium tosylate compositions. Glycopyrronium tosylate is useful for the treatment of, among other conditions, hyperhidrosis.

Abstract: In one example in accordance with the present disclosure, a method may include retrieving, at a memory management unit (MMU), encrypted data from a memory via direct memory access and determining, at the MMU, a peripheral that is the intended recipient of the encrypted data. The method may also include accessing an application key used for transmission between an application and the peripheral, wherein the application key originates from the application and decrypting, at the MMU, the encrypted data using the application key and transmitting the decrypted data to the peripheral.

Abstract: Provided herein are processes for making and methods of using salts of glycopyrronium, including solid forms and forms suitable for use as topicals. Disclosed here are processes for making salts of glycopyrronium, also processes for making compositions comprising salts of glycopyrronium, and methods of treating hyperhidrosis with salts of glycopyrronium as well as with compositions comprising salts of glycopyrronium such as, but not limited to, topical compositions. Disclosed herein are methods of treating hyperhidrosis including administering salts of glycopyrronium to subjects in need thereof.